PATENT CLAIM ANALYSIS

Application Number: 16033785
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "227200"]

Abstract:
The present invention provides a compound of formula I, having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

Claim (Index 16):
A compound of formula I according to any one of  claims 1 - 15 , wherein R 3  is methyl.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15558273', '14433769', '14877250', '15105725', '15735890']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8107971653888406
- 35 USC 102 Novelty (BERT): 0.6504963143727824
- Combined Prediction Score: 0.7947670802872349
- Mean Citation Score: 514.736308
- Max Citation Score: 746.1576
- Similarity Product: 554.6560512200832

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test